Back to results
US 10,308,937 B2Granted
Combination long acting compositions and methods for Hepatitis C
AssigneeGlaxoSmithKline Intellectual Property (No. 2) Limited
InventorsZhi Hong, Martin R. Leivers
Life of this patent
Estimating the term…
Abstract
The present Invention relates to pharmaceutical compositions useful in the treatment or prevention or cure of viral infections, such as HCV infections, and diseases associated with such infections.
Claims24
A method for the treatment of an HCV infection in a human having an HCV infection, comprising:
- administering to the human a long acting parenteral (LAP) pharmaceutical composition comprising a LAP HCV active agent, or a pharmaceutically acceptable salt thereof, wherein the LAP HCV agent is 6-(N-(7-chloro-1-hydroxy-1,3-dihydrobenzo[c][1 ,2]oxaborol-5-yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-N-methylbenzofuran-3-carboxamide, in combination with a compound of Formula IIA or IIB:
Dependencies are inferred from the claim text.